Chaim Lebovits - 06 May 2024 Form 4/A Insider Report for BRAINSTORM CELL THERAPEUTICS INC. (BCLI)

Signature
/s/ Chaim Lebovits
Issuer symbol
BCLI
Transactions as of
06 May 2024
Net transactions value
+$50,666
Form type
4/A
Filing time
31 Jul 2024, 16:06:39 UTC
Date Of Original Report
07 May 2024
Previous filing
25 Apr 2024
Next filing
07 May 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BCLI Common Stock Purchase $50,666 +135,000 +16% $0.3753 993,565 06 May 2024 Direct F1, F2
holding BCLI Common Stock 2,000,847 06 May 2024 See footnote F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On May 7, 2024, the Reporting Person filed a Form 4 which inadvertently included the incorrect transaction code due to an administrative error. This amendment is being filed solely to reflect the correct transaction code 'P' instead of transaction code 'A'.
F2 The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $0.3498 to $0.399, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of securities purchased at each separate price within the range set forth in this footnote (2) to this Form 4.
F3 Includes (i) 1,933,794 shares of Common Stock owned by ACCBT Corp. and (ii) 67,053 shares of Common Stock owned by ACC International Holdings Ltd. Reporting Person may be deemed the beneficial owner of these shares.